| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600015 | Q101-聚乙二醇重组人干扰素α2a注射液 | peginterferon alfa-2a | Injection | Biological Products(1) | New Drug Application | 2016-04-06 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2017-02-21 | view |
| CXSL1600117 | Q101-聚乙二醇重组人干扰素α2a注射液 | peginterferon alfa-2a | Injection | Biological Products(1) | New Drug Application | 2017-07-13 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | Certificate Issued | 2018-04-16 | view |